The store will not work correctly when cookies are disabled.
1-hexyl-5-phenyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
ID: ALA4293785
PubChem CID: 145988381
Max Phase: Preclinical
Molecular Formula: C17H24N4
Molecular Weight: 284.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCn1nnc2c1CCN(c1ccccc1)C2
Standard InChI: InChI=1S/C17H24N4/c1-2-3-4-8-12-21-17-11-13-20(14-16(17)18-19-21)15-9-6-5-7-10-15/h5-7,9-10H,2-4,8,11-14H2,1H3
Standard InChI Key: MSVGTEJCPXOZNL-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
5.5573 -10.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3549 -10.5228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6089 -9.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4066 -9.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6565 -8.8010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4542 -8.6319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3074 -11.4702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7895 -12.1346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3074 -12.7987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5252 -12.5463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8152 -12.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1092 -12.5463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1092 -11.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8152 -11.3195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5252 -11.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3997 -12.9509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6942 -12.5385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9847 -12.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9847 -13.7580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6841 -14.1704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3997 -13.7719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 10 1 0
12 11 1 0
12 13 1 0
14 13 1 0
15 14 1 0
10 15 2 0
7 15 1 0
16 12 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
16 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.41 | Molecular Weight (Monoisotopic): 284.2001 | AlogP: 3.42 | #Rotatable Bonds: 6 |
Polar Surface Area: 33.95 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.84 | CX LogP: 3.88 | CX LogD: 3.88 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.76 | Np Likeness Score: -1.49 |
References
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |